retatrutide trial data Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 conducted in the USA 💉𝗥𝗲𝘁𝗮𝘁𝗿𝘂𝘁𝗶𝗱𝗲'𝘀 𝗨𝗻𝗲𝘅𝗽𝗲𝗰𝘁𝗲𝗱 𝗦𝗶𝗱𝗲 𝗘𝗳𝗳𝗲𝗰𝘁: 𝗪𝗵𝗮𝘁

Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model

PMID: 18568020 Biaggioni I (2024): Adrenoceptor Agonists & Sympathomimetic Drugs (Chapter 9)

Gastroparesis & Stomach Paralysis Gastroparesis (stomach paralysis) is a severe condition where the muscles in the stomach stop working correctly, preventing the stomach from emptying

Your blood sugar management is usually assessed using blood tests that measure hemoglobin A1c (HbA1c) in your blood

Researchers looked at the health records of 95,490 people in Sweden, 81 per cent of whom had anxiety, 55 per cent had depression and 36 per cent had both conditions

The brand specialises in methylation-support formulations and supplements designed for individuals with MTHFR and other genetic variants affecting nutrient metabolism